US · SERVICES-HOSPITALS · SMALL CAP
Jrsis Health Care Corporation JRSS
11 fiscal years on record · USD · FY2023 reported
SEC FILINGS ONLY
Revenue · FY2023
$3.5M
▲ 101.4% vs FY2022
EPS · FY23
$-0.00
Dividend / sh · FY23
—
Payout · FY23
—
ROE · FY23
—
Net margin · FY23
-2.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.5M
Revenue, FY2023 · full 11-year series below
Revenue
Net income
The company lost 2 cents on every revenue dollar this year.
Per share
USD -0.00
Diluted EPS, FY2023
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2023
ROE
Operating margin-5.4%
Net margin-2.3%
Return on assets-3.9%
Returned to shareholders
—
returned in FY2023 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−34.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−54.1%
−34.4%
−2.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.08B
Shares outstanding, FY2023
Change, 5 years+25.6%
Change, 10 years—
The share count grew 26% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.1M
total assets, end of FY2023
Total assetsUSD 2.1M
EquityUSD -137,406.00
CashUSD 118,114.00
Gross debtUSD 43,663.00
Net debtUSD -74,451.00
Current ratio0.80×
The company holds more cash than debt.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
·
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
−0.00
−0.01
0.17
0.15
0.05
0.13
0.32
0.25
0.13
0.05
0.29
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
−5.2
15.5
22.6
6.1
14.7
47.6
67.3
63.0
49.6
84.4
Shares out B
0.08
0.08
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
35 of 35
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed